http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101432246-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 |
filingDate | 2012-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2014-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101432246-B1 |
titleOfInvention | Composition for preventing and treating autoimmune diseases comprising metformin |
abstract | More particularly, the present invention relates to the use of Mepholin for the prevention and treatment of autoimmune diseases caused by Th17 cells by inhibiting the differentiation of Th17 cells. Accordingly, the present invention relates to a pharmaceutical composition for the prevention and treatment of autoimmune diseases comprising a mefomine or a pharmaceutically acceptable salt thereof. |
priorityDate | 2011-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 137.